New York, New York, United States
I am a scientist with extensive experience in oncogenic viruses, infectious diseases and, more recently, vaccines. In addition to authoring manuscripts and books, I have developed a broad technical expertise across molecular and translational research. I also had the opportunity to collaborate across different stages of vaccine development, which broadened my experience and perspective. Over the past 5 years, I have led and mentored a multidisciplinary team of scientists, strengthening my leadership in both project management and people development while improving operational efficiency and team performance.
. Development of vaccines based on VSV for Lassa, Marburg, SARS-CoV-2 and Sudan viruses. . Team lead of the Vector Evaluation and Quality Control Team involved in the production and analysis of pre-clinical vaccine material. . Coordinates a team of scientists and junior scientists.
. Associate Editor at Journal of Medical Virology
. Detection of ultra-low viral load with ddPCR in samples infected with SHIV and SIV.
• Detection of SARS-CoV-2 in COVID-19 patients’ tissues. • Mice experiments with Zika virus (ZIKV) intracranial injections for 10x single cells and spatial sequencing. • Investigate how herpesviruses circular RNA functions differs from linear RNA counterparts and interferes with tumor development. • Established protocols for viral circular RNA detection in the lab. • Implemented 3D culture in the lab.